Raymond James & Associates decreased its stake in shares of Cognex Co. (NASDAQ:CGNX) by 20.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 151,097 shares of the scientific and technical instruments company’s stock after selling 37,738 shares during the period. Raymond James & Associates owned about 0.09% of Cognex worth $6,740,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of CGNX. Capital Analysts LLC raised its stake in Cognex by 1,180.6% during the second quarter. Capital Analysts LLC now owns 2,305 shares of the scientific and technical instruments company’s stock worth $103,000 after acquiring an additional 2,125 shares during the period. Braun Bostich & Associates Inc. acquired a new stake in Cognex during the first quarter worth about $125,000. Summit Trail Advisors LLC raised its stake in Cognex by 4,133.9% during the first quarter. Summit Trail Advisors LLC now owns 183,625 shares of the scientific and technical instruments company’s stock worth $184,000 after acquiring an additional 179,288 shares during the period. Caisse DE Depot ET Placement DU Quebec acquired a new stake in Cognex during the first quarter worth about $213,000. Finally, Point72 Asia Hong Kong Ltd raised its stake in Cognex by 3,200.0% during the first quarter. Point72 Asia Hong Kong Ltd now owns 4,290 shares of the scientific and technical instruments company’s stock worth $223,000 after acquiring an additional 4,160 shares during the period. 90.28% of the stock is currently owned by institutional investors and hedge funds.

In other Cognex news, Director Jerry A. Schneider sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $52.50, for a total value of $131,250.00. Following the sale, the director now owns 4,500 shares in the company, valued at $236,250. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Anthony Sun sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $53.01, for a total transaction of $530,100.00. Following the completion of the sale, the director now owns 284,262 shares in the company, valued at approximately $15,068,728.62. The disclosure for this sale can be found here. Insiders sold 27,500 shares of company stock worth $1,493,200 in the last 90 days. 5.40% of the stock is owned by company insiders.

Several equities research analysts recently weighed in on the stock. BidaskClub upgraded shares of Cognex from a “hold” rating to a “buy” rating in a research note on Wednesday. Zacks Investment Research lowered shares of Cognex from a “buy” rating to a “hold” rating in a research note on Tuesday, August 28th. Northcoast Research lowered shares of Cognex from a “buy” rating to a “neutral” rating and set a $54.00 price objective on the stock. in a research note on Friday, August 24th. They noted that the move was a valuation call. ValuEngine upgraded shares of Cognex from a “strong sell” rating to a “sell” rating in a research note on Tuesday, July 31st. Finally, Sanford C. Bernstein upgraded shares of Cognex from a “market perform” rating to an “outperform” rating and set a $40.10 price objective on the stock in a research note on Wednesday, August 1st. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the company. Cognex has a consensus rating of “Hold” and an average price target of $54.79.

Shares of NASDAQ:CGNX opened at $57.94 on Wednesday. Cognex Co. has a 52 week low of $39.90 and a 52 week high of $72.99. The company has a market capitalization of $10.14 billion, a price-to-earnings ratio of 42.11 and a beta of 1.66.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Monday, July 30th. The scientific and technical instruments company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.30 by $0.02. Cognex had a net margin of 20.57% and a return on equity of 22.95%. The company had revenue of $211.26 million for the quarter, compared to analyst estimates of $204.87 million. During the same quarter last year, the business earned $0.63 earnings per share. Cognex’s revenue was up 18.6% compared to the same quarter last year. equities research analysts forecast that Cognex Co. will post 1.19 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, August 31st. Shareholders of record on Friday, August 17th were paid a $0.045 dividend. The ex-dividend date of this dividend was Thursday, August 16th. This represents a $0.18 annualized dividend and a dividend yield of 0.31%. Cognex’s payout ratio is currently 12.41%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Article: What is a stock buyback?

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.